Priming hMSCs with a putative anti-cancer compound, myrtucommulone-a: a way to harness hMSC cytokine expression via modulating PI3K/Akt pathway?
Crossref DOI link: https://doi.org/10.1007/s13277-015-3995-9
Published Online: 2015-09-03
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Iskender, Banu
Izgi, Kenan
Sakalar, Cagri
Canatan, Halit
Text and Data Mining valid from 2015-09-03